267 related articles for article (PubMed ID: 18791075)
1. Schizophrenia: a computational reinforcement learning perspective.
Frank MJ
Schizophr Bull; 2008 Nov; 34(6):1008-11. PubMed ID: 18791075
[No Abstract] [Full Text] [Related]
2. [The dopaminergic hypothesis revisited].
Guillin O
Encephale; 2006 Oct; 32(5 Pt 4):S908-11; discussion S912. PubMed ID: 17119503
[No Abstract] [Full Text] [Related]
3. Dopamine hypothesis of schizophrenia: making sense of it all.
Toda M; Abi-Dargham A
Curr Psychiatry Rep; 2007 Aug; 9(4):329-36. PubMed ID: 17880866
[TBL] [Abstract][Full Text] [Related]
4. [The involvement of D-1 and D-2 dopamine receptors in the effects of neuroleptics and the pathogenesis of schizophrenia].
Wielgosz M
Psychiatr Pol; 1992; 26(5):357-64. PubMed ID: 1363827
[TBL] [Abstract][Full Text] [Related]
5. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
Winterer G
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
[TBL] [Abstract][Full Text] [Related]
6. Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.
Yang CR; Chen L
Neuroscientist; 2005 Oct; 11(5):452-70. PubMed ID: 16151046
[TBL] [Abstract][Full Text] [Related]
7. Phenomenological modelling of some mechanisms in schizophrenia.
Schwegler H
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S43-9. PubMed ID: 16508895
[TBL] [Abstract][Full Text] [Related]
8. The D2 receptor: love it and leave it.
Pickar D
Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
[No Abstract] [Full Text] [Related]
9. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
10. Model-based parametric study of frontostriatal abnormalities in schizophrenia patients.
Tanaka S
BMC Psychiatry; 2010 Feb; 10():17. PubMed ID: 20187970
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic dysfunction in schizophrenia: salience attribution revisited.
Heinz A; Schlagenhauf F
Schizophr Bull; 2010 May; 36(3):472-85. PubMed ID: 20453041
[TBL] [Abstract][Full Text] [Related]
12. Occupancy of striatal dopamine D2 receptors.
Baron JC
Psychiatry Res; 1995 Nov; 61(4):285-7. PubMed ID: 8748471
[No Abstract] [Full Text] [Related]
13. [Neurobiology in the neuropharmacology of antipsychotic drugs].
Tassin JP
Encephale; 2006 Jan; 32 Pt 2():S6-7. PubMed ID: 16800077
[No Abstract] [Full Text] [Related]
14. Balanced Activation of Striatal Output Pathways by Faster Off-Rate PDE10A Inhibitors Elicits Not Only Antipsychotic-Like Effects But Also Procognitive Effects in Rodents.
Harada A; Kaushal N; Suzuki K; Nakatani A; Bobkov K; Vekich JA; Doyle JP; Kimura H
Int J Neuropsychopharmacol; 2020 Feb; 23(2):96-107. PubMed ID: 31689714
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
Shim JC; You YS; Kelly DL
J Clin Psychopharmacol; 2008 Jun; 28(3):353-4. PubMed ID: 18480699
[No Abstract] [Full Text] [Related]
16. [Deficit schizophrenia: from pharmacology to clinical practice].
Tassin JP
Encephale; 1996 Jun; 22 Spec No 2():9-12. PubMed ID: 8767035
[TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyl transferase and schizophrenia.
Sagud M; Mück-Seler D; Mihaljević-Peles A; Vuksan-Cusa B; Zivković M; Jakovljević M; Pivac N
Psychiatr Danub; 2010 Jun; 22(2):270-4. PubMed ID: 20562760
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation.
Meisenzahl EM; Scheuerecker J; Zipse M; Ufer S; Wiesmann M; Frodl T; Koutsouleris N; Zetzsche T; Schmitt G; Riedel M; Spellmann I; Dehning S; Linn J; Brückmann H; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):522-31. PubMed ID: 17151834
[TBL] [Abstract][Full Text] [Related]
19. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
Leuner K; Müller WE
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
[TBL] [Abstract][Full Text] [Related]
20. The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.
Nomoto M; Fukuda T
Adv Neurol; 1993; 60():119-22. PubMed ID: 8093574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
